Schedule 13D ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: 2024-04-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-24-000986
- Form type
- SC 13D
- Filer
- Foresite Capital Fund V, L.P.
- CIK
- CIK 1792204
- Filed
- Apr 05, 2024
- Reporting period
- Apr 03, 2024
- Description
- Schedule 13D beneficial ownership